Deer­field com­mits $50M-plus to trans­la­tion­al drug R&D at the Broad

Deer­field Man­age­ment and the fa­mous Broad In­sti­tute of MIT and Har­vard have come up with a nov­el plan for pur­su­ing trans­la­tion­al drug re­search work.

In the deal an­nounced this morn­ing, Deer­field will in­vest more than $50 mil­lion in­to projects at the Broad over the next five years. And the biotech in­vestor plans to fol­low up with sup­port to cre­ate new biotechs out of the re­search, with “sig­nif­i­cant ad­di­tion­al re­sources” avail­able for de­vel­op­ment work.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.